Literature DB >> 32150760

Tuning cytokines enriches dendritic cells and regulatory T cells in the periodontium.

R Warren Sands1,2,3, Catia S Verbeke1,2, Kazuhisa Ouhara4,5, Eduardo A Silva1,2,6, Susan Hsiong1, Toshihisa Kawai4,7, David Mooney1,2.   

Abstract

BACKGROUND: Periodontal disease results from the pathogenic interactions between the tissue, immune system, and microbiota; however, standard therapy fails to address the cellular mechanism underlying the chronic inflammation. Dendritic cells (DC) are key regulators of T cell fate, and biomaterials that recruit and program DC locally can direct T cell effector responses. We hypothesized that a biomaterial that recruited and programmed DC toward a tolerogenic phenotype could enrich regulatory T cells within periodontal tissue, with the eventual goal of attenuating T cell mediated pathology.
METHODS: The interaction of previously identified factors that could induce tolerance, granulocyte-macrophage colony stimulating factor (GM-CSF) and thymic stromal lymphopoietin (TSLP), with the periodontitis network was confirmed in silico. The effect of the cytokines on DC migration was explored in vitro using time-lapse imaging. Finally, regulatory T cell enrichment in the dermis and periodontal tissue in response to alginate hydrogels delivering TSLP and GM-CSF was examinedin vivo in mice using immunohistochemistry and live-animal imaging.
RESULTS: The GM-CSF and TSLP interactome connects to the periodontitis network. GM-CSF enhances DC migration in vitro. An intradermal injection of an alginate hydrogel releasing GM-CSF enhanced DC numbers and the addition of TSLP enriched FOXP3+ regulatory T cells locally. Injection of a hydrogel with GM-CSF and TSLP into the periodontal tissue in mice increased DC and FOXP3+ cell numbers in the tissue, FOXP3+ cells in the lymph node, and IL-10 in the tissue.
CONCLUSION: Local biomaterial-mediated delivery of GM-CSF and TSLP can enrich DC and FOXP3+ cells and holds promise for treating the pathologic inflammation of periodontal disease.
© 2020 American Academy of Periodontology.

Entities:  

Keywords:  adult periodontitis; biomaterials; dendritic cell; immunotherapy; regulatory T cells

Mesh:

Substances:

Year:  2020        PMID: 32150760      PMCID: PMC7483931          DOI: 10.1002/JPER.19-0411

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  44 in total

1.  Regulatory T cells attenuate experimental periodontitis progression in mice.

Authors:  Gustavo P Garlet; Cristina R Cardoso; Flavia S Mariano; Marcela Claudino; Gerson F de Assis; Ana P Campanelli; Mario J Avila-Campos; João S Silva
Journal:  J Clin Periodontol       Date:  2010-07       Impact factor: 8.728

2.  Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.

Authors:  Hassen Kared; Annie Masson; Homa Adle-Biassette; Jean-François Bach; Lucienne Chatenoud; Flora Zavala
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

Review 3.  Periodontal diseases.

Authors:  Denis F Kinane; Panagiota G Stathopoulou; Panos N Papapanou
Journal:  Nat Rev Dis Primers       Date:  2017-06-22       Impact factor: 52.329

4.  Differentiation, apoptosis, and GM-CSF receptor expression of human gingival fibroblasts on a titanium surface treated by a dual acid-etched procedure.

Authors:  Luca Ramaglia; Gaetano Di Spigna; Gabriele Capece; Carolina Sbordone; Salvatore Salzano; Loredana Postiglione
Journal:  Clin Oral Investig       Date:  2015-04-17       Impact factor: 3.573

5.  Langerhans cells down-regulate inflammation-driven alveolar bone loss.

Authors:  Moran Arizon; Itay Nudel; Hadas Segev; Gabriel Mizraji; Mazal Elnekave; Karina Furmanov; Luba Eli-Berchoer; Björn E Clausen; Lior Shapira; Asaf Wilensky; Avi-Hai Hovav
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

6.  High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Authors:  Paolo Serafini; Rebecca Carbley; Kimberly A Noonan; Gladys Tan; Vincenzo Bronte; Ivan Borrello
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

7.  Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.

Authors:  Simon Gaudreau; Chantal Guindi; Michaël Ménard; Gilles Besin; Gilles Dupuis; Abdelaziz Amrani
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

8.  Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor.

Authors:  J M Wang; S Colella; P Allavena; A Mantovani
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

9.  Characterization of the Protective Role of Regulatory T Cells in Experimental Periapical Lesion Development and Their Chemoattraction Manipulation as a Therapeutic Tool.

Authors:  Carolina Favaro Francisconi; Andreia Espindola Vieira; Claudia Cristina Biguetti; Andrew J Glowacki; Ana Paula Favaro Trombone; Ariadne Letra; Renato Menezes Silva; Charles S Sfeir; Steven R Little; Gustavo Pompermaier Garlet
Journal:  J Endod       Date:  2015-11-14       Impact factor: 4.171

10.  Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.

Authors:  G Kaplan; G Walsh; L S Guido; P Meyn; R A Burkhardt; R M Abalos; J Barker; P A Frindt; T T Fajardo; R Celona
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Biologics and their delivery systems: Trends in myocardial infarction.

Authors:  Matthew A Borrelli; Heth R Turnquist; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-03-26       Impact factor: 17.873

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.